4Blank SG,Mann SJ,James GD,et al.Isolated elevation of diastolic blood pressure:real or artificial hypertention[J].Hypertension,1995,26(3):383-389.
5Minuz P,Barrow SE,Cockcroft JR,et al.Prostacyclin and thromboxane biosynthesis in mild essential hypertension[J].Hypertension,1990,15(5):469-474.
6Kuklinska AM,Mroczko B,Musial WJ,et al.Diagnostic biomarkers of essential arterial hypertension:the value of prostacyclin,nitric oxide,oxidized-LDL,and peroxide measurements[J].Int Heart J,2009,50(3):341-351.
7Félétou M,Khler R,Vanhoutte PM.Endothelium-derived vasoactive factors and hypertension:possible roles in pathogenesis and as treatment targets[J].Curr Hypertens Rep,2010,12(4):267-275.
8Joint National Committee on Detection,Evaluation,and Treatment of High Blood Pressure.The fifth report of Joint National Committee on Detection,Evaluation,and Treatment of High Blood Pressure(JNCV)[S].Arch Intern Med,1993,153(2):154-183.
9Franklin SS,Lopez VA,Wong ND,et al.Single versus combined blood pressure components and risk for cardiovascular disease:the Framingham Heart Study[J].Circulation,2009,119(2):243-250.
10Kelly TN,Gu D,Chen J,et al.Hypertension subtype and risk of cardiovascular disease in Chinese adults[J].Circulation,2008,118(15):1558-1566.
